Filing Details

Accession Number:
0001209191-21-021809
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-03-18 17:08:23
Reporting Period:
2021-03-16
Accepted Time:
2021-03-18 17:08:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1094038 Marker Therapeutics Inc. MRKR Pharmaceutical Preparations (2834) 880277072
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1694560 New Enterprise Associates 16, L.p. 1954 Greenspring Drive
Suite 600
Timonium MD 21093
No No Yes No
1712881 Nea Partners 16, L.p. 1954 Greenspring Drive
Suite 600
Timonium MD 21093
No No Yes No
1712882 Nea 16 Gp, Llc 1954 Greenspring Drive
Suite 600
Timonium MD 21093
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-03-16 5,714,285 $1.75 10,714,285 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The shares are directly held by New Enterprise Associates 16, L.P. ("NEA 16"), and indirectly held by NEA Partners 16, L.P. ("NEA Partners"), the sole general partner of NEA 16, NEA 16 GP, LLC ("NEA 16 GP"), the sole general partner of NEA Partners 16, and the individual managers of NEA 16 GP (NEA Partners 16, NEA 16 GP and the individual managers of NEA 16 GP, together, the "Indirect Reporting Persons").The individual managers of NEA 16 GP are Forest Baskett, Ali Behbahani, Carmen Chang, Anthony A. Florence, Jr., Mohamad Makhzoumi, Josh Makower, Scott D. Sandell, Peter W. Sonsini and Paul Walker. The Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares of the Issuer held by NEA 16 in which the Indirect Reporting Persons have no pecuniary interest.